Home Sky Medical Technology Ltd.

Sky Medical Technology Ltd.

COVID-19 Patients at Higher Risk of Dangerous Blood Clots Reports Sky Medical Technology

With VTE recognized as a major contributor to COVID-19 multi-organ failure, anticoagulation is critical and drug prophylaxis is the primary intervention, especially for immobile patients on ventilators at risk of VTE in ICU. Similar increases in thrombotic risk were seen with H1N1m influenza (Swine Flu).

The geko Device Makes its Debut

Jason Snibbe, MD, a fellow from the Kerlan-Jobe Institute, USC team surgeon, and an orthopedic surgeon practicing in Los Angeles, CA presented a real-world total knee replacement patient case study to an audience of over 900 orthopedic surgeons and healthcare professionals.

FDA Clears GEKO DEVICE for Use in Non-Surgical Patients at Risk for DVT

The company headquarters are located in the United Kingdom and backed by leading international investors in both healthcare and technology.